Social Analytics for the Life Sciences Industry
Our physician influence networking technologies empower customers with actionable insights, quantified metrics and timely alerts to impending change, enabling them to formulate on-target strategic responses with significant resource efficiency and increased effectiveness.
Qforma helps clients to understand, monitor and predict behavior in all relevant communities.
Customized robust solutions quantify the impact of influence per physician and identify community influence networks by analyzing practice patterns found in data. Qforma then delivers the physician influence and communication network infrastructure of every community.
Costs go down. Impact and results go up. While the math seems simple, and even though much of the business world have incorporated so-called “Network Effects” into their promotional spectrum, most pharmaceutical companies have NOT.
- Compliant Speaker Selection 82%
- Event Program Design 91%
- Augment Call Planning 94%
A Sophisticated Blend of Experience, Technology & Brainpower
Qforma differentiates itself from other analytics firms through sophisticated pattern recognition technologies and predictive modeling expertise developed by a team of physicists, mathematicians and software engineers.
Qforma anomaly detection algorithms identify practice behavior outliers, usage propensities and practice patterns via comprehensive analysis of patient-level, pharmacy, hospital, and qualitative data. These capabilities enable us to find answers to complex problems faced by our clients.
Smart & Savvy
Qforma technology delivers, to both large and specialty pharmaceutical companies, a means for understanding and penetrating professional relationship networks in any territory. It quickly distinguishes physicians who drive practice decision patterns within these networks.
Founders, Leaders, Innovators
Engineered Intelligence Meet Human Experience
Chief Executive Officer
Jeff is a proven operating leader with over 15 years of success leading transformational growth and profitability in middle market, B2B companies in both private and PE-owned settings. He has profitably driven revenues on a global basis through the organic development of leap-frog technology, strategic acquisitions and an unrelenting focus on customer needs, execution and quality.
Most recently, Jeff was CEO & President of Avatar Solutions, a company that is engaged in improving patient care experience and employee engagement surveying. While at Avatar, Jeff executed on a turnaround strategy for the company, including reorganizing and upgrading the management team, improving operational quality and reliability, and transform outdated technology.
Prior to Avatar, Jeff was CEO & President of AHM, LLC, a company he joined in December, 2001 and grew from single-digit to several hundred million in annual revenues over 6 years. Under Jeff’s leadership, AHM built a highly efficient and scalable business model that meets critical needs for regulatory compliance control and financial management in the global pharmaceutical industry. As a result of these strategies, AHM became the market leader in this sector, providing this technology-enabled service to over 40 pharmaceutical companies, including 15 of the top twenty industry leaders, many of whom have relied upon these innovative solutions for several years.
Prior to AHM, Jeff was a management consultant at Marakon Associates, a consultancy that advises CEO’s and their senior management teams on developing rigorous strategic management capabilities. He worked with Fortune 500 companies in both the U.S. and U.K. in the aerospace, defense, high-tech and financial services industries.
Jeff also served in the U.S. Navy as a nuclear submarine officer. He held a variety of operational roles and was a certified Navy Nuclear Engineer.
Jeff holds a B.S. in Industrial Engineering from Purdue University and an MBA from the MIT Sloan School of Management. He has authored a number of published articles relating to regulatory compliance in the pharmaceutical industry and speaks regularly at related conferences.
Robert Holmes, Ph.D.
Chief Science Officer
Dr. Robert Holmes is a physicist and mathematician with 30 years experience in taking advanced analytical techniques out of the computer lab and applying them to real-world engineering and commercial problems. He has leveraged his skills in simulation, system development, and artificial intelligence for a range of international clients; from energy utilities in the US and UK to commercial banking in China.
Robert has been with Qforma since its inception, where he was instrumental in developing its analytics and software.
Despite being born and raised in Manchester, England, Robert failed to pledge allegiance to either of its football teams. He received his MA in physics from Oxford University in 1983, his Ph.D. in 1987 and his MBA in 2000. He was included in PharmaVoice magazine’s “100 most inspiring People in Life Sciences” in 2012.
Chief Financial Officer
Ed Mendham has 20 years’ experience in progressive financial and accounting roles. Before joining Qforma, he served as Vice President, Finance for Advanced Health Media (AHM), a provider of software solutions, sales force logistics and outsourced speaker bureau management for the pharmaceutical industry. He was responsible for overseeing corporate financial planning and strategy and brought structure and process to the company’s financial functional areas. Prior to his role at AHM, Ed had served in various financial/accounting roles at JDS Uniphase (fiber optic manufacturer). Ed has an MBA from Rider University and is also a CPA.